Table 1.
D-Ala-D-Asp [%] | D-Ala-D-Ala [%] | D-Ala [%] | |
---|---|---|---|
No vancomycin* | 76 | 24 | 0 |
15 μg/ml vancomycin | 48 | 47 | 5 |
25 μg/ml vancomycin | 45 | 48 | 7 |
No oritavancin | 76 | 24 | 0 |
15 μg/ml oritavancin | 83 | 17 | 0 |
25 μg/ml oritavancin | 89 | 11 | 0 |
On the basis of three different growths, the relative concentrations are ±1 of those shown (e.g., 76 ±1%).